NRXN1 and attention deficit-hyperactivity disorder: Notably, NRXN1 was impacted in 10 subjects (three SCZ, six ASD, and one ADHD); deletions of 18p11.21 impacting novel candidate genes (GNAL, LDLRAD4, and SEH1L) were in four cases (three ASD, one ADHD).